US2022118064A1PendingUtilityA1

Multi-supplement compositions

57
Assignee: MELALEUCA INCPriority: Jan 2, 2015Filed: Dec 27, 2021Published: Apr 21, 2022
Est. expiryJan 2, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61K 36/742A61K 31/122A23K 20/126A61K 33/06A61K 31/385A61K 31/593A61K 33/42A23K 10/18A61K 31/10A61K 36/16A23L 33/175A23K 20/168A61K 36/9068A61K 31/7004A23K 20/189A61K 36/82A61K 36/87A61K 35/60A61K 38/4873A61K 31/202A23K 20/24A23L 33/115A61K 45/06A61K 35/747A23L 33/15A61K 36/81A23K 20/158A23K 20/142A23L 33/135A23K 20/174A61K 31/726A23K 20/111A61K 31/702A61K 31/355A61K 31/12A61K 35/745A23K 20/132A23L 33/105A23L 33/29A23K 20/121A23K 20/163A23L 33/10A23L 33/11A61K 36/68A61K 31/435A61K 31/685A61K 31/205A61P 39/06A23K 20/10A23Y 2300/49A23Y 2220/73A23Y 2220/17A23Y 2300/55A23Y 2300/25A23Y 2220/67A23Y 2220/03A61K 36/74A23V 2400/113A23V 2400/125A23V 2400/169A23V 2400/175A23V 2400/517A23V 2400/531A23V 2400/533
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A multi-supplement composition comprising:
 (a) a probiotic supplement;   (b) a multivitamin and mineral supplement;   (c) an antioxidant supplement; and   (d) an anti-inflammatory supplement.   
     
     
         2 . The composition of  claim 1 , further comprising a fish oil supplement. 
     
     
         3 . The composition of  claim 1 , wherein the probiotic supplement comprises:
 (i) from about 5 billion to about 15 billion cfu of a mixture of  Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactis , and  Bifidobacterium bifidum ; and   (ii) a filler having a water activity less than 0.2.   
     
     
         4 . The composition of  claim 1 , wherein the probiotic supplement comprises a capsule or a tablet. 
     
     
         5 . The composition of  claim 1 , wherein said dietary supplement of a Supplement Formulation A releases said  Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactis , and  Bifidobacterium bifidum  within an intestine of a mammal following oral administration to said mammal; 
     
     
         6 . A multi-supplement composition comprising:
 (a) a dietary supplement of a Supplement Formulation E comprising:
 (i) a grape seed extract, and 
 (ii) an enzyme selected from the group consisting of a fungal protease, an acid stable protease, and bromelain; 
   (b) a dietary supplement of a Supplement Formulation I comprising Vitamin K 2  and Vitamin D 3 ;   (c) a dietary supplement of a Supplement Formulation J comprising CoQ10, a tocotrienol, and alpha-lipoic acid; and   (d) a dietary supplement of a Supplement Formulation K comprising:
 (i) a sterol compound, and 
 (ii) an omega 3 fatty acid. 
   
     
     
         7 . A supplement composition comprising:
 (a) from about 5 billion to about 15 billion cfu of a mixture of  Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium lactis , and  Bifidobacterium bifidum,      (b) a fat-soluble antioxidant,   (c) a phenolic compound,   (d) a water soluble antioxidant,   (e) an iridoid,   (e) a ginger component,   (f) an anthocyanin,   (g) at least one agent selected from the group consisting of a coumarin, a curcuminoid, and a green tea extract;   (h) a grape seed extract,   (i) an enzyme selected from the group consisting of a fungal protease, an acid stable protease, and bromelain, and   (j) a mineral-amino acid compound/polysaccharide complex.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.